{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:50:11Z","timestamp":1765486211609,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Gulhane Military Medical Academy"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.tjog.2018.04.015","type":"journal-article","created":{"date-parts":[[2018,6,3]],"date-time":"2018-06-03T22:09:35Z","timestamp":1528063775000},"page":"411-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effects of different therapeutic modalities on cardiovascular risk factors in women with polycyst\u0131c ovary syndrome: A random\u0131zed controlled study"],"prefix":"10.1016","volume":"57","author":[{"given":"Serkan","family":"Bodur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgur","family":"Dundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"Kanat-Pektas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Ferdi","family":"Kinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Tutuncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tjog.2018.04.015_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2009-1985","article-title":"Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial","volume":"95","author":"Agarwal","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.tjog.2018.04.015_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000341838","article-title":"Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome","volume":"40","author":"Bajuk Studen","year":"2013","journal-title":"Front Horm Res"},{"issue":"2","key":"10.1016\/j.tjog.2018.04.015_bib3","first-page":"465","article-title":"Clinical, hormonal and metabolic characteristics of polycystic ovary syndrome among obese and nonobese women in the Croatian population","volume":"37","author":"Baldani","year":"2013","journal-title":"Coll Antropol"},{"key":"10.1016\/j.tjog.2018.04.015_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/786362","article-title":"Polycystic ovary syndrome. 2015. Important underrecognized cardiometabolic risk factor in reproductive-age women","author":"Baldani","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"1","key":"10.1016\/j.tjog.2018.04.015_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/2042018812437355","article-title":"The effects of old, new and emerging medicines on metabolic aberrations in PCOS","volume":"3","author":"Bargiota","year":"2012","journal-title":"Therapeut Adv Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.tjog.2018.04.015_bib6","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"18","author":"Carmina","year":"2003","journal-title":"Human Reprod"},{"key":"10.1016\/j.tjog.2018.04.015_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000341840","article-title":"Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome","volume":"40","author":"Carmina","year":"2013","journal-title":"Front Horm Res"},{"issue":"11","key":"10.1016\/j.tjog.2018.04.015_bib8","doi-asserted-by":"crossref","first-page":"e80416","DOI":"10.1371\/journal.pone.0080416","article-title":"Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome","volume":"8","author":"Comim","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.tjog.2018.04.015_bib9","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.tjog.2018.04.015_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.tjog.2018.04.015_bib11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.tjog.2018.04.015_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejogrb.2013.01.015","article-title":"Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome","volume":"168","author":"El-Mesallamy","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.tjog.2018.04.015_bib13","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.fertnstert.2009.10.016","article-title":"Comparison of effects of 3 mg drospirenone plus 20 \u03bcg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"94","author":"Fruzzetti","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.tjog.2018.04.015_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2265.2012.04466.x","article-title":"Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome","volume":"78","author":"Harmanci","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.tjog.2018.04.015_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/humrep\/deg056","article-title":"Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome","volume":"18","author":"Ib\u00e1\u00f1ez","year":"2003","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.tjog.2018.04.015_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/humrep\/dei329","article-title":"Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil\/lymphocyte ratio","volume":"21","author":"Ib\u00e1\u00f1ez","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.tjog.2018.04.015_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6823-12-9","article-title":"Ethinylestradiol 30\u03bcg-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?","volume":"12","author":"Ilie","year":"2012","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.tjog.2018.04.015_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1507\/endocrj.EJ11-0023","article-title":"Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome","volume":"59","author":"Koiou","year":"2012","journal-title":"Endocr J"},{"key":"10.1016\/j.tjog.2018.04.015_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0277-9536(01)00034-X","article-title":"\u201cThe thief of womanhood\u201d: women's experience of polycystic ovary syndrome","volume":"54","author":"Kitzinger","year":"2002","journal-title":"Soc Sci Med"},{"issue":"4","key":"10.1016\/j.tjog.2018.04.015_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.contraception.2005.09.015","article-title":"A\u00a0prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol","volume":"73","author":"Kluft","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.tjog.2018.04.015_bib21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3904\/kjim.2013.28.4.456","article-title":"Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome","volume":"28","author":"Lee","year":"2013","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.tjog.2018.04.015_bib22","first-page":"97","article-title":"Polycystic ovary syndrome. Long term sequelae and management","volume":"54","author":"Legro","year":"2002","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.tjog.2018.04.015_bib23","article-title":"Obesity differentially affects phenotypes of polycystic ovary syndrome","volume":"7","author":"Moran","year":"2012","journal-title":"Int J Endocrinol"},{"issue":"10","key":"10.1016\/j.tjog.2018.04.015_bib24","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2002-021688","article-title":"Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.tjog.2018.04.015_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.tjog.2018.04.015_bib26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.tjog.2018.04.015_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000341837","article-title":"Insulin sensitizers in polycystic ovary syndrome","volume":"40","author":"Pasquali","year":"2013","journal-title":"Front Horm Res"},{"issue":"10","key":"10.1016\/j.tjog.2018.04.015_bib28","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1093\/humrep\/des225","article-title":"Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study","volume":"27","author":"Piltonen","year":"2012","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.tjog.2018.04.015_bib29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"Randeva","year":"2012","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1016\/j.tjog.2018.04.015_bib30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.clinbiochem.2006.07.003","article-title":"Interactions of serum hsCRP with apoB, apoB\/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease","volume":"39","author":"Rasouli","year":"2006","journal-title":"Clin Biochem"},{"issue":"4","key":"10.1016\/j.tjog.2018.04.015_bib31","first-page":"259","article-title":"Effects of metformin therapy on markers of coagulation disorders in hyperinsulinemic women with polycystic ovary syndrome","volume":"82","author":"Serdy\u0144ska-Szuster","year":"2011","journal-title":"Ginekol Pol"},{"issue":"4","key":"10.1016\/j.tjog.2018.04.015_bib32","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"Shaw","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.tjog.2018.04.015_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.fertnstert.2008.09.034","article-title":"Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy","volume":"93","author":"Teede","year":"2010","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.tjog.2018.04.015_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.08.036","article-title":"Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation","volume":"85","author":"Vanky","year":"2006","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.tjog.2018.04.015_bib35","first-page":"CD003990","article-title":"Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2","volume":"28","author":"Visser","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tjog.2018.04.015_bib36","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/humrep\/dei100","article-title":"Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome","volume":"20","author":"Vural","year":"2005","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.tjog.2018.04.015_bib37","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1210\/jc.2010-1709","article-title":"Menstrual irregularity and cardiovascular mortality","volume":"96","author":"Wang","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.tjog.2018.04.015_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.steroids.2011.12.002","article-title":"Dyslipidemia in PCOS","volume":"77","author":"Wild","year":"2012","journal-title":"Steroids"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455918300810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455918300810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:16:13Z","timestamp":1760897773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455918300810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1028455918300810"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2018.04.015","relation":{},"ISSN":["1028-4559"],"issn-type":[{"type":"print","value":"1028-4559"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of different therapeutic modalities on cardiovascular risk factors in women with polycyst\u0131c ovary syndrome: A random\u0131zed controlled study","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2018.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}